Works by DI GIUSEPPE, GIANFRANCO
Results: 19
Why do some glucose‐lowering agents improve non‐alcoholic fatty liver disease whereas others do not? A narrative review in search of a unifying hypothesis.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2023, v. 39, n. 7, p. 1, doi. 10.1002/dmrr.3668
- By:
- Publication type:
- Article
Effects of PCSK9 inhibition on glucose metabolism and β-cell function in humans: a pilot study.
- Published in:
- Frontiers in Endocrinology, 2023, p. 01, doi. 10.3389/fendo.2023.1124116
- By:
- Publication type:
- Article
The Interplay between Immune System and Microbiota in Diabetes.
- Published in:
- Mediators of Inflammation, 2019, p. 1, doi. 10.1155/2019/9367404
- By:
- Publication type:
- Article
Lynch Syndrome and Thyroid Nodules: A Single Center Experience.
- Published in:
- Genes, 2024, v. 15, n. 7, p. 859, doi. 10.3390/genes15070859
- By:
- Publication type:
- Article
Prediabetes: how pathophysiology drives potential intervention on a subclinical disease with feared clinical consequences.
- Published in:
- Minerva Endocrinology, 2021, v. 46, n. 3, p. 272, doi. 10.23736/S2724-6507.21.03405-9
- By:
- Publication type:
- Article
Advancing Diabetes Research: A Novel Islet Isolation Method from Living Donors.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 11, p. 5936, doi. 10.3390/ijms25115936
- By:
- Publication type:
- Article
Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional β cells in predicting diabetes.
- Published in:
- Journal of Clinical Investigation, 2021, v. 131, n. 12, p. 1, doi. 10.1172/JCI146788
- By:
- Publication type:
- Article
Circulating 1,5-Anhydroglucitol as a Biomarker of ß-cell Mass Independent of a Diabetes Phenotype in Human Subjects.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 10, p. 2833, doi. 10.1210/clinem/dgac444
- By:
- Publication type:
- Article
Erythrocyte Membrane Fluidity and Omega-3 Fatty Acid Intake: Current Outlook and Perspectives for a Novel, Nutritionally Modifiable Cardiovascular Risk Factor.
- Published in:
- Nutrients, 2024, v. 16, n. 24, p. 4318, doi. 10.3390/nu16244318
- By:
- Publication type:
- Article
Physical Activity and Type 2 Diabetes: In Search of a Personalized Approach to Improving β-Cell Function.
- Published in:
- Nutrients, 2023, v. 15, n. 19, p. 4202, doi. 10.3390/nu15194202
- By:
- Publication type:
- Article
Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features.
- Published in:
- Nutrients, 2023, v. 15, n. 1, p. 18, doi. 10.3390/nu15010018
- By:
- Publication type:
- Article
The influence of insulin and incretin-based therapies on renal tubular transport.
- Published in:
- Journal of Nephrology (JNonline), 2024, v. 37, n. 8, p. 2139, doi. 10.1007/s40620-024-02048-w
- By:
- Publication type:
- Article
Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes.
- Published in:
- Diabetologia, 2023, v. 66, n. 2, p. 354, doi. 10.1007/s00125-022-05814-2
- By:
- Publication type:
- Article
Dapagliflozin-Induced Myocardial Flow Reserve Improvement is not Associated with HDL Ability to Stimulate Endothelial Nitric Oxide Production.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 1, p. 257, doi. 10.1007/s13300-023-01491-5
- By:
- Publication type:
- Article
Lysophosphatidylinositols Are Upregulated After Human β-Cell Loss and Potentiate Insulin Release.
- Published in:
- Diabetes, 2024, v. 73, n. 1, p. 93, doi. 10.2337/db23-0205
- By:
- Publication type:
- Article
290-OR: Altered In-Situ Expression of Proinsulin-Insulin in Pancreatic Islets Reflects Metabolic and Molecular Defects in Type 2 Diabetic and Glucose-Intolerant Living Donors.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-290-OR
- By:
- Publication type:
- Article
1795-P: Proinsulin-Insulin Pancreatic Islets In-situ Expression Mirrors Metabolic Defects Observed in Type 2 Diabetic and Glucose Intolerant Living Donors.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1795-P
- By:
- Publication type:
- Article
2295-PUB: Impaired First-Phase Insulin Secretion Predicts the Development of Hyperglycemia in a Human Model of Acute Beta-Cell Mass Reduction.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-2295-PUB
- By:
- Publication type:
- Article
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives.
- Published in:
- Cardiovascular Diabetology, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12933-024-02539-x
- By:
- Publication type:
- Article